Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine
about
Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertasesRole of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1Isolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytesRole of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transportN-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and InfectivityAntiviral effects of an iminosugar derivative on flavivirus infectionsNovel glycosylation pathways of retroviral envelope proteins identified with avian reticuloendotheliosis virusMethods for the synthesis of polyhydroxylated piperidines by diastereoselective dihydroxylation: exploitation in the two-directional synthesis of aza-C-linked disaccharide derivatives.Selective inhibition of human immunodeficiency virus type 1 replication by the (-) but not the (+) enantiomer of gossypolSynergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidineAssays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytesInhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cellsFangchinoline inhibits human immunodeficiency virus type 1 replication by interfering with gp160 proteolytic processingNonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1Functional contributions of carbohydrate on AIDS virus glycoproteinCharacterization of the biosynthesis of human immunodeficiency virus type 1 Env from infected T-cells and the effects of glucose trimming of Env on virion infectivity.Inhibitors of glycoprotein processing alter T-cell proliferative responses to antigen and to interleukin 2Transcriptome analysis of the whitefly, Bemisia tabaci MEAM1 during feeding on tomato infected with the crinivirus, Tomato chlorosis virus, identifies a temporal shift in gene expression and differential regulation of novel orphan genes.Aminosugar derivatives as potential anti-human immunodeficiency virus agents.Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases.N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropismFundamental difference in the content of high-mannose carbohydrate in the HIV-1 and HIV-2 lineages.Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16.HIV entry and envelope glycoprotein-mediated fusionHuman retroviruses after 20 years: a perspective from the past and prospects for their future control.Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycinAntiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.Evaluation of Cynanchum otophyllum glucan sulfate against human immunodeficiency virus and herpes simplex virus as a microbicide agent.Antiviral therapy for human immunodeficiency virus infectionsN-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposureStrategies in the treatment of AIDS and related diseases: the lessons of cancer chemotherapy.Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processingCellular and viral mechanisms of HIV-1 transmission mediated by dendritic cellsHIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.Processing of the glycoprotein of feline immunodeficiency virus: effect of inhibitors of glycosylation.Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus.Mutational analysis of conserved N-linked glycosylation sites of human immunodeficiency virus type 1 gp41
P2860
Q24534205-5DBA5401-1EB1-470D-842F-D6EB3E697FEAQ24615670-50F2D196-893C-4237-BE00-8F9B8DE87084Q24621842-004051C1-2ED8-4268-BCC9-9C4A08770887Q24643931-F496721A-C522-4491-9729-DD370B9F2818Q24646043-C61229C2-F4B3-4E56-89E5-CDAACBB29CD2Q27472669-95DDA823-D91C-43C2-A9AA-1097F5F02FF7Q27472863-83487FED-9F0E-463E-BBA4-AC892DFB5C89Q27486829-93C9ACB3-A14D-4BC1-B865-2E5E2AC37F80Q28195751-0018F5EA-46CB-41D5-94CD-4C2810C6105AQ28354386-5FDC6186-49FF-4437-AB23-C7872C5CFAF5Q28354620-7B758495-9B02-41C9-BDCF-7C29D92C5E22Q28368240-B75C7934-AFB6-4F78-BF02-7122E5043AFDQ28369132-51B0179F-D02D-440B-9628-DA8923CCB16EQ28480389-9BD09062-A721-4438-8D27-B3E265ABBF65Q28646731-5D58DB9D-33EE-48FE-BA05-5B99B92A20B5Q30397572-6ED12F3B-3FED-47B9-B2EA-5BBFB98C34A5Q31510236-A8E53822-1B96-49B5-8F46-9B00FF3450F1Q33636440-9BE6D599-1F38-446D-AA92-EB248C9C9BFAQ33660421-9D5E4DBD-1175-44A1-93F5-523066F8D15CQ33681820-1471BF3D-5E6D-4059-ACD5-3A7EBAD2465CQ33827027-329328BA-9753-47B3-B71D-2920E6C123A0Q33842455-7FE7C6AB-8E06-4504-998A-87AB84F36AFFQ34120130-6622C2B3-463B-4AC2-B143-D4540989A7C5Q34178201-E4683AD8-D9E2-4F53-972D-9EEAAE6E2093Q34435855-09B94F7E-FCB4-45AD-ABF5-0A9B4D42D66EQ34792498-629C4A54-89BC-4DCA-BE90-A9DFBFD88893Q34998032-5CEE12E2-7DAA-442E-9D18-29640AB7428CQ35101574-3A8DDCAA-6CF3-4FA7-93F0-8C06E580F5FCQ35325810-995901EA-DBAF-4724-822C-B5F9BF6C7330Q35365285-2FDB06A9-BB0E-4144-9C11-1FF72C291986Q35366050-C7AB1634-EEC2-4B6A-AAA7-36982FD42249Q35870879-BE4851C5-B8CE-4C3F-AAC3-0773E1DF3839Q35870903-C005166A-19D3-4191-9793-4C8C4AD000B5Q35930774-93003BD0-C7B1-490A-8112-21ADD01F851AQ36094966-09F1D866-ED99-40A8-B1CF-2C314F749F66Q36448906-D48458F0-8F37-4CED-8F58-FA8BD1E4AD0EQ36664069-FCF9823E-2E9F-4281-A343-267B0CC7CB57Q36681510-5D4763BE-CC57-4BAD-A5EA-0CFCF5747419Q36684349-9A0DB518-674D-403E-A74A-C3D2C8E28E5AQ36694013-3212FF12-8BE7-4713-ACD5-15F5EB7BD3EE
P2860
Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine
description
1987 nî lūn-bûn
@nan
1987 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Inhibition of human immunodefi ...... replication by castanospermine
@ast
Inhibition of human immunodefi ...... replication by castanospermine
@en
Inhibition of human immunodefi ...... replication by castanospermine
@nl
type
label
Inhibition of human immunodefi ...... replication by castanospermine
@ast
Inhibition of human immunodefi ...... replication by castanospermine
@en
Inhibition of human immunodefi ...... replication by castanospermine
@nl
prefLabel
Inhibition of human immunodefi ...... replication by castanospermine
@ast
Inhibition of human immunodefi ...... replication by castanospermine
@en
Inhibition of human immunodefi ...... replication by castanospermine
@nl
P2093
P2860
P356
P1476
Inhibition of human immunodefi ...... replication by castanospermine
@en
P2093
B D Walker
K Kozarsky
L Rohrschneider
M Kowalski
P2860
P304
P356
10.1073/PNAS.84.22.8120
P407
P577
1987-11-01T00:00:00Z